Syncona (SYNC) founds, builds, and funds life science companies, seeking to build a relatively concentrated/high conviction portfolio of up to 15-20 companies. It aims to invest at a very early stage, partnering with academics and takes a long-term approach, seeking to maintain a majority equity stake over a company’s development. SYNC has the flexibility to run winners, such that the portfolio can be very concentrated. The majority of SYNC’s companies will be located in the UK or Europe, which ....
19 Mar 2021
Syncona - Overview
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Syncona - Overview
Syncona Ltd GBP (SYNC:LON) | 123 -2.5 (-1.6%) | Mkt Cap: 802.4m
- Published:
19 Mar 2021 -
Author:
William Heathcoat Amory -
Pages:
6
Syncona (SYNC) founds, builds, and funds life science companies, seeking to build a relatively concentrated/high conviction portfolio of up to 15-20 companies. It aims to invest at a very early stage, partnering with academics and takes a long-term approach, seeking to maintain a majority equity stake over a company’s development. SYNC has the flexibility to run winners, such that the portfolio can be very concentrated. The majority of SYNC’s companies will be located in the UK or Europe, which ....